Latest News

Simple two-drug combination proves effective in reducing risk of stroke

Results of a Phase III clinical trial showed that a simple drug regimen of two anti-clotting drugs -- clopidogrel and aspirin -- lowered the risk of stroke by almost one-third, compared to the standard therapy of aspirin alone, when given to patients who had minor or transient stroke symptoms to prevent subsequent attacks.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • MS drug candidate shows new promise

  • Pathway that contributes to Alzheimer's disease revealed by research

  • Domestic violence likely more frequent for same-sex couples

  • Physical activity in older adults linked to brain white-matter integrity

  • Targeted radiation, drug therapy combo less toxic for recurrent head, neck cancers

  • 3-D shape processing in brain: New discovery on how objects, places are processed

  • Suicide Prevention Requires Access to Effective, Evidence-Based Treatment

  • Down Syndrome helps researchers understand Alzheimer's disease

  • Providing private mental health service to veterans: Hurdles, challenges, advice

  • Gun deaths twice as high among African-Americans as white citizens in US

  •